Phase 1, open-label study of MEDI-547 in patients with...

Investigational New Drugs 2013 / 02 Vol. 31; Iss. 1

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

Christina M. Annunziata, Elise C. Kohn, Patricia LoRusso, Nicole D. Houston, Robert L. Coleman, Manuela Buzoianu, Gabriel Robbie, Robert Lechleider
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
DOI:
10.1007/s10637-012-9801-2
Date:
February, 2013
File:
PDF, 154 KB
english, 2013
Conversion to is in progress
Conversion to is failed